McDonald’s Corp. shares slumped on Tuesday after Redburn Atlantic slapped the burger chain with its sole sell rating, saying ...

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing ...

A recent study reveals a surge in the use of GLP-1 medications, such as Ozempic and Wegovy, among younger age groups.

The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

We are just starting to learn more about the systemic impact of these medications,” Dr. Shiara Ortiz-Pujols told The Post.

Injectable GLP-1 drugs for obesity have been found to produce smaller weight loss in a real-world setting compared to ...

The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...

Metsera has linked its amylin analog to 8.4% placebo-adjusted weight loss at Day 36, advancing its push to develop an ...

Registered dietitian Ayla Barmmer told The Post that about 15% of her patients taking GLP-1 medications have struggled to ...

A study of real-world and virtual patients suggests that a less frequent dosing of glucagon-like peptide 1 receptor agonists ...